Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-059241

SVP, COO & CFO sold 8,276 shares at $16.93 ($140,113)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP, COO & CFO 2020-11-16 Sale −8,276 $16.93 $140,113 226,973 D
Open-market sales · 8,276 sh · avg $16.93 · $140,113
Loading xslF345X03/doc4.xml…